Gender differences in drug use and expenditures in a privately insured population of older adults
Gender differences in drug use and expenditures in a privately insured population of older adults
复制标题
DOI：
10.1089/jwh.2005.14.73
复制
发表时间：
2005-01-01
影响因子：
3.5
通讯作者：
Trinh, Y
中科院分区：
文献类型：
--
作者：
Correa-De-Araujo, R;Miller, E;Trinh, Y
我们研究了65岁及以上的医疗保险和私人保险老年人在处方药使用和支出方面的性别差异，使用了医疗支出小组调查家庭部分收集的处方药购买的全国代表性样本数据。总体而言，女性在药物上的支出约为1，178美元，比男性的平均支出1，009美元高出约17%。老年妇女占人口的50.7%，处方药的年均总支出为69.3亿美元，而男子为57.7亿美元。妇女比男子更有可能使用一些治疗类药物-镇痛剂、激素和精神治疗剂-和治疗亚类药物-甲状腺药物、考克斯-2抑制剂和抗抑郁药。女性在一些治疗类----激素、精神治疗剂和止痛剂----和治疗亚类----抗糖尿病药物和β受体阻滞剂方面的人均处方量也较高。可以说，处方药是预防老年人疾病、残疾和死亡的最重要的医疗保健技术。至关重要的是，老年妇女和男子能够适当获得处方药。鉴于这一优先群体，特别是妇女的经济脆弱性，《医疗保健现代化法》规定的扩大药品覆盖面对实现这一目标特别重要。
We examine gender differences in use and expenditures for prescription drugs among Medicare and privately insured older adults aged 65 and over, using data on a nationally representative sample of prescription drug purchases collected for the Medical Expenditure Panel Survey Household Component. Overall, women spent about $1,178 for drugs, about 17% more than the $1,009 in average expenditures by men. Older women constituted 50.7% of the population and had average annual aggregate expenditures for prescribed medicines of $6.93 billion compared to $5.77 billion for men. Women were more likely than men to use drugs from a number of therapeutic classes-analgesics, hormones and psychotherapeutic agents - and therapeutic subclasses - thyroid drugs, COX-2 inhibitors and anti-depressants. Women also had higher average prescriptions per user for a number of therapeutic classes - hormones, psychotherapeutic agents and analgesics - and therapeutic subclasses - anti-diabetic drugs and beta blockers. Prescribed medications are, arguably, the most important healthcare technology in preventing illness, disability, and death in older adults. It is critical that older women and men have proper access to prescribed medicines. Given the financial vulnerability of this priority population, particularly women, the expanded drug coverage available under the Medicare Modernization Act is of particular relevance in meeting this goal.